Janeway Lesions: A Comprehensive Medical Guide

Overview

Janeway lesions are painless, erythematous or hemorrhagic macules, papules, or nodules that appear on the palms and soles. They are a classic peripheral manifestation of infective (bacterial) endocarditis, particularly subacute (culture‑negative) forms, but can also be seen in other systemic infections and vasculitic conditions.

• Who is affected? Adults with underlying heart valve disease, prosthetic valves, or a history of intravenous drug use (IVDU) are most at risk. Janeway lesions are uncommon in children.
• Prevalence – In modern series of infective endocarditis (IE), Janeway lesions are reported in 3–10 % of patients, down from 10–30 % in historical series because of earlier diagnosis and antibiotic use.^{[1] Mayo Clinic}
• Why they matter – Although they are painless, their presence points to systemic embolization of septic micro‑thrombi and signals a potentially serious underlying infection.

Symptoms

Janeway lesions themselves are usually painless, but they often occur alongside other systemic signs of infective endocarditis. Below is a complete symptom list, grouped by organ system.

Skin Findings

• Janeway lesions – Small, flat or slightly raised, erythematous‑purple spots, 0.5–1 cm in diameter, located on the palms, soles, and sometimes the lateral aspects of fingers and toes. They tend to be non‑tender and may resolve spontaneously within weeks.
• Osler nodes – Tender, erythematous nodules on the pads of the fingers or toes (different from Janeway lesions; painful).
• Roth spots – Retinal hemorrhages with a white centre, seen on fundoscopic exam.
• Splinter hemorrhages – Linear, red‑brown streaks under the nail plate.

Cardiac Symptoms

• Fever (often >38 °C/100.4 °F)
• New or changing heart murmur
• Palpitations

General Constitutional Symptoms

• Fatigue, malaise, weight loss
• Night sweats
• Myalgias or arthralgias
• Shortness of breath (if heart failure develops)

Neurologic & Embolic Symptoms

• Seizures or focal neurologic deficits (stroke from emboli)
• Confusion or altered mental status

Causes and Risk Factors

Janeway lesions are not a disease themselves; they are a physical sign that results from septic emboli derived from infected cardiac valves.

Primary Causes

• Infective endocarditis (IE) – Most commonly caused by Staphylococcus aureus, Streptococcus viridans, or Enterococci. The lesions represent micro‑abscesses in the dermal capillaries.
• Other systemic infections – Rarely seen with disseminated fungal infections (e.g., Candida) or mycobacterial disease.
• Vasculitis and immune‑complex disorders – Conditions such as systemic lupus erythematosus (SLE) can mimic Janeway lesions, though true Janeway lesions are strongly linked to IE.

Key Risk Factors for Developing IE (and thus Janeway lesions)

1. Pre‑existing valvular disease (e.g., rheumatic heart disease, mitral valve prolapse, bicuspid aortic valve).
2. Prosthetic heart valves or prior valve replacement surgery.
3. History of intravenous drug use – especially with S. aureus infection.
4. Recent dental procedures without prophylaxis in high‑risk patients.
5. Chronic indwelling catheters, hemodialysis, or immunosuppression.

According to the CDC, the incidence of infective endocarditis in the United States is estimated at 3–10 cases per 100,000 person‑years, with higher rates in the above high‑risk groups.^{[2] CDC}

Diagnosis

Diagnosing Janeway lesions is straightforward (clinical inspection), but confirming the underlying cause requires a systematic approach.

Clinical Evaluation

• Detailed skin examination of palms and soles.
• Cardiac auscultation for new murmur.
• History focusing on risk factors (IVDU, dental work, prosthetic valves).

Laboratory Tests

• Blood cultures – Obtain at least three sets from separate venipuncture sites before starting antibiotics. Positive cultures are a major Duke criterion for IE.
• Complete blood count (CBC) – often shows anemia of chronic disease and leukocytosis.
• Inflammatory markers – Elevated ESR and CRP.
• Serology – For atypical organisms (Coxiella, Bartonella) when cultures are negative.

Imaging & Specialized Tests

• Echocardiography – Transthoracic (TTE) first; transesophageal (TEE) if TTE is nondiagnostic or prosthetic valve is present. Vegetations, abscesses, or new regurgitation confirm IE.
• Fundoscopy – To detect Roth spots.
• Skin biopsy (rare) – Histology shows septic emboli with neutrophilic infiltrates; mainly used when diagnosis is uncertain.
• CT/MRI – If embolic complications (stroke, abscess) are suspected.

The modified Duke criteria, which combine clinical, microbiologic, and imaging findings, remain the gold standard for diagnosing infective endocarditis.^{[3] American Heart Association}

Treatment Options

Management focuses on eradicating the underlying infection and addressing any embolic complications.

Antibiotic Therapy

• Empiric regimen (pending cultures) – Vancomycin + Gentamicin + Ceftriaxone for broad coverage of MRSA, streptococci, and enterococci (adjust based on local resistance patterns).
• Targeted therapy – Tailored to organism and susceptibility; typical duration 4–6 weeks of intravenous antibiotics.
• Monitoring of drug levels (vancomycin troughs) and renal function is essential.

Surgical Interventions

• Indications include heart failure from valve dysfunction, uncontrolled infection, large vegetations (>10 mm) with embolic risk, or prosthetic valve involvement.
• Valve repair or replacement surgery performed by cardiothoracic surgeons.

Supportive and Adjunctive Measures

• Fever control with acetaminophen (avoid NSAIDs if renal concerns).
• Management of heart failure – diuretics, ACE inhibitors as appropriate.
• Anticoagulation is generally avoided unless there is a coexisting indication (e.g., atrial fibrillation) because of bleeding risk from embolic lesions.

Lifestyle & Preventive Measures During Treatment

• Strict adherence to IV antibiotic schedule (often via an outpatient parenteral antimicrobial therapy program).
• Good oral hygiene & prophylactic antibiotics before dental work for high‑risk patients.
• Avoidance of IV drug use; referral to substance‑use treatment programs.

Living with Janeway Lesions

While the lesions themselves are painless, living with the underlying condition can be challenging.

Daily Management Tips

1. Skin care – Keep hands and feet clean; use mild soap; avoid trauma that could cause secondary infection.
2. Monitor lesion changes – Photograph lesions; note any rapid growth, ulceration, or pain – report to your clinician.
3. Medication adherence – Set alarms or use a pill organizer for oral antibiotics after the IV course.
4. Follow‑up appointments – Cardiology and infectious disease visits every 1–2 weeks during treatment.
5. Nutrition – High‑protein diet to support healing; adequate hydration.
6. Activity level – Gradual increase as tolerated; avoid strenuous activity that could dislodge vegetations during acute phase.

Psychosocial Support

• Join support groups for endocarditis survivors.
• Consider counseling for anxiety or depression related to prolonged therapy.
• Engage family members in care planning to improve adherence.

Prevention

Since Janeway lesions are a manifestation of infective endocarditis, preventing IE directly reduces the risk.

• Prophylactic antibiotics – Recommended before certain dental or respiratory procedures for patients with prosthetic valves, prior IE, or certain congenital heart diseases (per AHA guidelines).^{[4] AHA}
• Oral hygiene – Brush twice daily, floss, and see a dentist regularly; untreated dental disease is a common portal of entry for bacteria.
• IV drug use cessation – Access to needle‑exchange programs and addiction treatment.
• Skin and wound care – Prompt cleaning of cuts; avoid sharing personal items that might be contaminated.
• Regular medical follow‑up – Annual echocardiograms for known valve disease.

Complications

If the underlying infective endocarditis is not promptly treated, several serious complications can arise.

• Systemic embolization – Stroke, splenic infarct, renal infarct, or limb ischemia.
• Heart failure – Due to valvular destruction or regurgitation.
• Abscess formation – Perivalvular or myocardial abscesses requiring surgery.
• Immune complex phenomena – Glomerulonephritis, vasculitis, or arthritis.
• Septic shock – Widespread infection leading to hypotension and organ failure.
• Mortality – Overall 30‑day mortality for left‑sided IE ranges from 10–25 %; higher in patients with delayed diagnosis or persistent embolic phenomena.^{[5] WHO}

When to Seek Emergency Care

References

1. “Infective Endocarditis,” Mayo Clinic, accessed April 2026.
2. Centers for Disease Control and Prevention. “Endocarditis Surveillance,” 2023.
3. American Heart Association. “Guidelines for the Management of Infective Endocarditis,” 2023.
4. Habib G, et al. “2023 ESC Guidelines for the prevention, diagnosis and treatment of infective endocarditis.” European Heart Journal, 2023.
5. World Health Organization. “Global Burden of Infective Endocarditis,” 2022.